>
COMMANDS Global: GP Symbol: IBM FA
↑↓ Navigate Enter Open Esc Close ` Toggle
Home
Home
Chart
AI
AI Chat
CLI
Markets
Markets
Today
Heatmap
Market Groups
Collections
News
Market News
Stock News
Categories
Social Sentiment
Market TV
Press Releases
Stocks
Indices
Sectors
Industries
Spreads
Intraday
Movers
Scanners
Earnings
Recommendations
Price Targets
Dividends
Splits
Insider Trades
SEC Filings
Transcripts
Institutions
Ratings
IPOs
Threshold List
ESG
Seasonality
Funds
US Majors
Popular ETFs
Dividend ETFs
ETF Categories
ETF List
Closed End Funds
Mutual Funds
MLPs
REITs
Commodities
Main Commodities
All Commodities
FX
Global Rates
Cross Currency Rates
Crypto
Main Crypto
All Crypto
Economy
Economic Calendar
Indicators
Market Risk Premium
Tools
Watchlist
Portfolios
Screeners
Chart
Compare
Correlations
Spreads
Aggregate
Backtest
Formula Scanner
Custom Formulas
Scoring Model
Time Series
Market Events
Machine Learning
Quant Tools
My
Notebook
Recommendations
Highlights
Todos
Symbol
Overview
Chart
Historical Prices
News
Financials
Earnings
Earnings Estimates
Earnings Call Transcripts
Analyst Recommendations
Price Targets
Peers
Institutional Holders
Insider Transactions
SEC Filings
Dividends
Seasonality
Volatility
Beta
Options Chain
ESG Score
Resources
Apps Directory
Market FAQs
Documentation
Directory
Videos
Roadmap
About Us
Pricing

Global Standardized Financials

4.87 0.18 (3.84%) 04/14/2026
Foghorn Therapeutics Inc. (FHTX)
Income Statement
(Values in Thousands)
 Q4 2025 (Dec 31, 2025)Q3 2025 (Sep 30, 2025)Q2 2025 (Jun 30, 2025)Q1 2025 (Mar 31, 2025)Q4 2024 (Dec 31, 2024)Q3 2024 (Sep 30, 2024)Q2 2024 (Jun 30, 2024)Q1 2024 (Mar 31, 2024)Q4 2023 (Dec 31, 2023)Q3 2023 (Sep 30, 2023)Q2 2023 (Jun 30, 2023)Q1 2023 (Mar 31, 2023)Q4 2022 (Dec 31, 2022)Q3 2022 (Sep 30, 2022)Q2 2022 (Jun 30, 2022)Q1 2022 (Mar 31, 2022)Q4 2021 (Dec 31, 2021)Q3 2021 (Sep 30, 2021)Q2 2021 (Jun 30, 2021)Q1 2021 (Mar 31, 2021)Q4 2020 (Dec 31, 2020)Q3 2020 (Sep 30, 2020)Q2 2020 (Jun 30, 2020)Q1 2020 (Mar 31, 2020)Q4 2019 (Dec 31, 2019)Q3 2019 (Sep 30, 2019)Q2 2019 (Jun 30, 2019)Q1 2019 (Mar 31, 2019)Q2 2018 (Jun 30, 2018)Q1 2018 (Mar 31, 2018)
Net Income-21,664-15,849-17,936-18,834-19,503-19,122-22,979-25,016
Revenue9,2478,1537,5575,9522,8567,8086,8885,050
Cost Of Revenue80220,002900
Gross Profit8,445-11,8496,6575,9522,8567,8086,8885,050
Operating Expenses28,0416,65227,75428,86526,86131,66033,52033,244
Selling General and Administrative Expenses6,7976,6526,8627,2396,3536,9717,3257,710
Research and Development Expenses22,94620,00220,89221,62620,50824,68923,79725,534
Other Expenses-1,702-20,0022,398
Cost And Expenses28,84326,65428,65428,86526,86131,66033,52033,244
Operating Income-19,596-18,501-21,097-22,913-24,005-23,852-26,632-28,194
Interest Income1,7122,0322,3092,6923,0963,4952,8702,439
Income Tax Expense
Income Before Tax-21,664-15,849-17,936-18,834-19,503-19,122-22,979-25,016
Earning Per Share Basic-0.35-0.25-0.28-0.30-0.31-0.31-0.45-0.59
Earning Per Share Diluted-0.35-0.25-0.28-0.30-0.31-0.31-0.45-0.59
weighted Average Shares Outstanding62,98163,02962,97862,84962,60362,60351,58042,429
weighted Average Shares Outstanding (Diluted)62,98163,02962,97862,84962,60362,60351,58042,429
Gross Margin0.91-1.450.881.001.001.001.001.00
EBIT Margin-2.03-1.84-2.25-3.71-8.14-2.96-3.40-5.42
Profit Margin-2.34-1.94-2.37-3.16-6.83-2.45-3.34-4.95
EBITDA-18,794-14,997-17,036-22,086-23,244-23,119-23,443-27,359
Earning Before Tax Margin-2.34-1.94-2.37-3.16-6.83-2.45-3.34-4.95

Market News ×
Loading news…